Legal Representation
Attorney
Tama L. Drenski
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 26, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 26, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Aug 22, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Aug 22, 2023 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Jul 18, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 18, 2023 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED |
| Jul 18, 2023 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
| May 23, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 23, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 3, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 18, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 13, 2023 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Sep 28, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Sep 28, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Sep 28, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Sep 14, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 14, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 14, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 21, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 21, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Mar 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 18, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 10, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 1, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
DNA screening for scientific research purposes; providing diagnostic services for others in the fields of science, namely, providing reagent sample diagnostic services for scientific research purposes and scientific research related thereto; providing reagent sample testing services for others in the fields of science and scientific research related thereto; computer services in the field of pharmaceutical and health care computer products, namely, computer diagnostic services and computer graphics services; providing an on-line network environment featuring technology that enables users to store, analyze and share data in the fields of life science; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; consulting services in the field of genetic science and scientific research related thereto; providing temporary use of on-line non-downloadable software for the custom design and ordering of assays and reagents; design and development of computer software for use in analysis of biomolecules relating to diagnosing or screening cancer; design and development of computer software for use in analysis of biomolecules relating to studying genetics and DNA; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to diagnosing or screening cancer; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to studying genetics and DNA; design and development of computer software for use in Software as a Service (SaaS) services for use in genetic and bioinformatics analysis; product development of products used in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, and for use in chemical screening and diagnostic services; product research and development services for others in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology research; scientific research services in the nature of chemical screening analysis for scientific research purposes; product research and development services for others in the field of chemicals and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, and for use in chemical screening and diagnostic services for others; product research, development and design of pharmaceutical and health care products; laboratory analysis in the field of nucleic acids and proteins, among which the analysis of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality specification of same; medical and scientific research in the field of cancer detection and treatment
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services; medical diagnostic testing and reporting services; clinical diagnostic services, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals, all for medical purposes; genetic testing for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
TAKE TWO TAKE TO
Classification
International Classes
042
044
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO